A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.
Network, HORIZON Investigators of the Huntington Study Group and European Huntington’s Disease. 2013. “A Randomized, Double-Blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease.”. JAMA Neurology 70 (1): 25-33.